Andy Jatis, PharmD, BCPS, BCCCP (@jatis_rx) header
Andy Jatis, PharmD, BCPS, BCCCP (@jatis_rx) profile picture

Cards/CTICU @NorthwesternMed ~ PGY2 CC & PGY1 @MayoPharmRes ~ @UIPharmacy 2021💊 ~ Interests: MCS, anticoagulation, shock

Chicago, IL
Joined May 2020
Propofol, a sedative hypnotic, is commonly used for RSI and procedural/ICU sedation but user beware. Propofol Infusion Syndrome (PRIS) although rare is a devastating side effect with up to 70% mortality. But how exactly does Propofol cause PRIS ⁉️ Follow the 🧵to learn more!
3
33
3
181
Fortunate to have some amazing research mentors during residency! Excited to see this project from PGY1 get to the finish line.
Online First! What is the incidence of clinically relevant bleeding in patients with low body weight, receiving prophylactic subcutaneous heparin? @jatis_rx @nei_scott and colleagues explore further in this informative study. buff.ly/3OwsUpE
1
25
4,160
Andy Jatis, PharmD, BCPS, BCCCP retweeted
Happy last day of residency to @NikithaYagnala and @jatis_rx! So proud of the incredible critical care pharmacists and people you are. @PennMedicine and @NorthwesternMed are so lucky to have you join their team, we will miss you so much! @MayoPharmRes #pharmicu
1
30
1,832
Andy Jatis, PharmD, BCPS, BCCCP retweeted
Dr. Nick Peters from the @PharmacyToDose critical care podcast provides insight on increasing your podcasting presence. Listen now: ow.ly/KwLT50OB7n3 @jatis_rx
1
1
9
2,233
Andy Jatis, PharmD, BCPS, BCCCP retweeted
Guess what just released? Two new ACCPPostgrads podcast episodes featuring Drs. Henry Okoroike and Mia Lussier! If you're interested in hearing their experience transitioning to new practitioner roles, listen in: ow.ly/Nz2Q50Nh7ES @henryco32 @MiaLussier
2
2
5
1,762
Andy Jatis, PharmD, BCPS, BCCCP retweeted
Next 🆙 Dr. Andy Jatis @jatis_rx discusses the ENCHATED2/MT Trial on intensive BP control after endovascular thrombectomy for acute ischemic stroke 🧠 🩺 #NCSPharmJC @neurocritical #PharmICU #NeuroTwitter
1
5
26
5,339
For a patient with acute ischemic stroke and large vessel occlusion receiving mechanical thrombectomy, what SBP goal do you target after successful endovascular reperfusion if the patient remains hypertensive? @neurocritical #NCSPharmJC
3%SBP < 120 mmHg
25%SBP 120-140 mmHg
51%SBP 140-160 mmHg
21%SBP 160-180 mmHg
248 votes • Final results
2
4
11
4,450
Clinical pearl 💊In patients with acute ischemic stroke and large vessel occlusion who remain hypertensive after successful endovascular reperfusion with thrombectomy, it is harmful to target a SBP < 120 mmHg (1/)
1
2
9
2,007
In the ECHANTED2/MT trial patients assigned to this intensive SBP goal had worse neurologic or functional outcomes at day 7 and day 90 compared to a non-intensive SBP goal of 140-180 mmHg #NCSPharmJC (2/2)
2
6
1,417
Andy Jatis, PharmD, BCPS, BCCCP retweeted
In today's Pharmacy Grand Rounds, @MayoClinicPharmRes @NikithaYagnala and @jatis_rx debate the role of terlipressin in hepatorenal syndrome. #TwitteRx @MayoClinicCCM @MayoClinicGIHep @accpcritprn @SCCM Subscribe to our PGR Podcast at mayocl.in/3jY3o1i
1
3
1
27
3,677
Andy Jatis, PharmD, BCPS, BCCCP retweeted
Some great company at the CPP reception last night. ☺️ @SCCM_CPP @MayoPharmRes
3
23
2,152
Andy Jatis, PharmD, BCPS, BCCCP retweeted
Mayo Clinic & Mayo Clinic Health System sites are hosting a virtual information session on 11/08 from 5-6 PM central! PGY1 and PGY1 community programs from Rochester (MN), Austin (MN), Mankato (MN), Eau Claire (WI), and La Crosse (WI) will be present. Register now!
Crit Care Lit Review 📒 Vasopressin 💉 VASST: Adding vaso ⬇️catecholamine dose and may reduce mortality for those with lower NE dose (<15 mcg/min) in septic shock VANISH: Adding vaso early to NE may ⬇️ need for RRT VANCS: Vaso ⬇️acute renal failure in vasoplegic shock #PharmICU
2
28
138
Vasopressin is released by the posterior pituitary when IV volume is ⬇️ V1 agonism 🟰 smooth muscle vasocontraction V2 agonism in renal collecting duct 🟰 increase water retention Given endogenous depletion of vaso in septic shock, start it early w/ NE for multimodal support
5
14
First stop on the PGY2 Critical Care Literature Review 🚂 Vasopressors with comparison of NE+Dobutamine vs EPI in septic shock🦠💉 🔑EPI causes type-B lactic acidosis due to its beta stimulation =⏫pyruvate dehydrogenase = ⏫ glucose and lactate independent of tissue dysoxia
1
6
64
What's your favorite ICU vasopressor trial and which additional studies would you like to see reviewed in this series? @accpcritprn @SCCM_CPP @NikithaYagnala @hannahbrokmeier @Dre_pharmd @nei_scott @pwierusz @EDWieru @KyleHessPharmD @theABofPharmaC @AJWPharm #pharmICU
4
6
Andy Jatis, PharmD, BCPS, BCCCP retweeted
Tuning in to her first Mayo Clinic Pharmacy Grand Rounds. @jatis_rx PGY2 critical care resident @MayoPharmRes presenting on fluid stewardship in the ICU
1
45
Calling all Pharmacy Residents + Fellows 📣If you are looking for a fun way to challenge your ability to interpret and visually display primary literature📚try out ACCP’s 1st ever Visual Abstract Challenge! Not sure how to get started on a visual abstract? Check out this article
ACCP is pleased to announce a new competition: the ACCP Visual Abstract Challenge! Open to current residents and fellows, prizes will be awarded to the top 5 participants. Read more about the competition in this month's Experts in Training: ow.ly/WUGN50JUbhP
1
4
17
Andy Jatis, PharmD, BCPS, BCCCP retweeted
Congratulations to @garrett_schramm and Ben Anderson on achieving FASHP in @ASHPOfficial. @MayoPharmRes is lucky to have you both!
4
18
Thanks for a great episode @PharmacyToDose and @CalleeBrooks 🥳
🚨NEW POD ALERT🚨 Nov/Dec Literature Review Series with @CalleeBrooks and @jatis_rx 6-pack of studies 🍻 Ventilator blues 🌩️ Lost in my mind 🧠 Don't go breaking my heart 💔 Front of the fridge 🏡 AND MORE! Come for the literature, stay for the Duke slander 👿
1
2
14